Results
Filtros
Cannabis: RDC 327 Review May Enhance Safety for Dentists in 2026
CFO supports dentists among authorized professionals to prescribe safely and with quality
RDC 327 review rapporteur bids farewell to Anvisa this Friday (19).
Rômison Rodrigues Mota leaves the position after a request for review delays the norm's vote; the topic will return to the regulatory agenda for 2026-2027
RDC 327 vote postponed at Anvisa; ABIQUIFI evaluates new deadline as "legitimate tool"
Brazilian Association of Pharmaceutical Inputs Industry trusts that director Thiago Campos' request for review will result in a more thorough analysis, maintaining the expectation of regulatory framework completion in January 2026
Anvisa warns of deadline for comments on agenda including review of RDC 327/2019
Submission of registrations, videos, and requests for confidentiality ends at 11:59 pm this Friday (5); item revising rules for cannabis products will be defined at the Dicol meeting on December 10
Cannabidiol grows over 70% in the pharmacy channel; Anvisa's RDC 327 review generates optimism in the sector
According to Filipe Campos, from Close-Up International, the market could expand even further with rule updates and greater medical adherence
RDC-327 and Cannabis Research: Lawyer Explains Proposal to Extend Deadline for Clinical Studies
On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa
Anvisa incorporates RDC 327 rules into Ordinance 344 and formalizes veterinary prescription of cannabis
11/26/2025Anvisa's update "mirrors" the rules for controlling cannabis products directly in the list of controlled substances and defines classification for industrial inputs
Anvisa suspends review of RDC 327 after director's request for further analysis
Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence
Anvisa suspends review of RDC 327 after director's request for further analysis
Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence
Anvisa may vote on maintaining or removing the agenda item for the review of RDC 327/2019, which regulates medicinal cannabis products
The item revising RDC 327/2019 reaches a decisive week at Anvisa, and the sector awaits to know if the topic will proceed to a vote or be postponed once again
Anvisa to resume voting on RDC 327 in the first meeting of 2026
Norm review may limit imports via RDC 660 if there is a national equivalent; director Thiago Campos presents dissenting vote
Anvisa to decide today the future of RDC 327 in a meeting that could redefine rules for cannabis products in Brazil
Norm that regulates manufacturing, importation, prescription, and inspection may be entirely revoked and replaced by a new regulatory framework; decision will be made at the Collegiate Board meeting.
Anvisa publishes proposal to update RDC 327 redefining rules for cannabis products in Brazil
Draft presents new regulatory framework, tightens requirements for Sanitary Authorization, and prohibits manipulation of cannabis derivatives
Proposal to restrict Cannabis importation (RDC 660) sparks reaction in the market
Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization
“It is important that the compounding pharmacy has access to all cannabis inputs" argues Marco Fiaschetti, from Anfarmag
With the revision of RDC 327/2019, compounding pharmacies gain space in the discussion on medicinal cannabis
Anvisa Collegiate Board has new composition defined after director's departure
Marcelo Mario Matos Moreira takes over as substitute in the Fourth Board, filling the vacancy of the former rapporteur of the review of RDC 327
CFF advocates for magistral manipulation amid changes in Cannabis regulation
Entity reinforces that personalized preparations are essential when industrialized products do not meet clinical needs
"More than business, it's life," says Paula Scanapieco talking about RDC 660 and international logistics
Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics
"More than business, it's life," says Paula Scanapieco talks about RDC 660 and international logistics
Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics
"Legally consolidates what had already been built," says veterinarian about new Anvisa regulation
Caroline Campagnone views RDC 999/2025 favorably, allowing veterinarians authorized by CFMV to prescribe medical cannabis